In the entire cohort (N = 163), the IHC results showed that the rate of PD-L1 detection was consistently low at 32.5%, but it was detected more frequently in metastatic sites than in the primary tumor site (χ2 = 4.66, p = 0.03). This evidence concerns the gene CD274 and neoplasm.